Skip to content

MDGL

Madrigal Pharmaceuticals, Inc.

Key figures

MetricLatest
Revenue$1.4B
Gross profit$1.2B
Operating income−$153M
Net income−$155M
EPS−$5.44
Free cash flow−$190M2025